Amedisys reports increase in net service revenue and adjusted net income for Q2 2024.

From GlobeNewswire: 2024-07-24 16:30:00

Amedisys, Inc. (NASDAQ: AMED) released financial results for the three and six-month periods ending June 30, 2024. Net service revenue increased to $591.2 million in the three-month period compared to $553.0 million in 2023. Adjusted net income per share rose from $1.37 in 2023 to $1.32 in 2024. Adjusted EBITDA totaled $73.2 million.

For the six-month period ending on June 30, 2024, Amedisys reported a net service revenue of $1,162.6 million, up from $1,109.4 million in 2023. Adjusted net income per diluted share increased to $2.35 from $2.38 in 2023. Adjusted EBITDA was $133.0 million.

The pending merger of Amedisys with UnitedHealth Group Incorporated led the company to forego a quarterly earnings call to discuss second quarter results. Amedisys provided non-GAAP financial measures, including adjusted EBITDA, adjusted net income, and adjusted net income per diluted share. Management believes these are useful gauges of the company’s performance.

Amedisys, Inc. is a healthcare at home company offering home health, hospice, and high acuity care services. More than 3,000 hospitals and 110,000 physicians have partnered with Amedisys. With approximately 18,800 employees across 37 states and the District of Columbia, Amedisys is dedicated to providing quality care to over 469,000 patients annually.

Forward-looking statements in the press release include risks and uncertainties related to the proposed merger with UnitedHealth Group, changes in Medicare payment levels, staffing shortages, compliance with regulations, and other factors impacting the company’s operations. Investors can find additional information on Amedisys’ website regarding financial information and company updates.



Read more at GlobeNewswire:: Amedisys Reports Second Quarter 2024 Financial Results